News
-
ICPerMed Webinar on International Personalised Medicine Perspectives – Recordings available
ICPerMed organised a webinar on international perspectives on personalised medicine on 25 September 2025. Recordings featuring Daryl Pritchard (Personalized Medicine Coalition, USA) and Mohamed Zahir Alimohamed (Tanzania Human Genetics Organisation, Tanzamia) are now available.
-
Call Announcement: RITC2026 – Test and Demonstration of Multimodal Data Approaches for Personalised Medicine
EP PerMed has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
-
Fast Track Validation Programme – eight Projects selected
EP PerMed is pleased to announce the selection of eight outstanding projects for its Fast Track Validation Programme, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine solutions across Europe.
-
Showcasing Impactful Research in Personalised Medicine: The PRETWINSCREEN project
EP PerMed has published its second success story, showcasing impactful research and collaborations in personalised medicine. The PRETWINSCREEN project developed new, tailored screening tools to improve the early detection of complications and personalise care in twin pregnancies, helping clinicians to better protect both mothers and babies.
EP PerMed NSC2025
Networking opportunity for previously funded projects in personalised medicine
Financial support (up to 30.000 euro) for researchers from previously funded projects in ERA PerMed and EP PerMed to organise a networking event (workshop or conference) addressing translational issues in personalised medicine!
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together around 60 partners from 25 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.